Back to top
more

SPDR S&P Pharmaceuticals ETF: (XPH)

(Delayed Data from NYSE) As of Oct 18, 2018 03:57 PM ET

 Add to portfolio

$45.55 USD

45.55
55,789

-0.28 (-0.61%)

Volume: 55,789

Zacks ETF Rank 2 - Buy   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NULL-Market: $45.49 -0.06 (-0.13 %) 7:58 PM ET

ETF Quote Details

Previous Close 45.83
Open 45.66
Bid 45.17
Ask 50.00
Day Low-High 45.16-46.04
52wk Low-High 38.71-49.97
Volume 55,789
NAV (month end) 48.56
Premium (+)/Discount (-) (month end)-2.73

Zacks Premium Research for XPH

Zacks ETF Rank Buy 2
ETF Risk High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.24 (0.53%)
Issuer STATE STREET GLOBAL ADVISORS

Benchmark for XPH

SP PHARMACEUTICALS SELECT INDUSTRY INDEX

The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.

Fund Summary for XPH

SPDR S&P PHARMACEUTICALS ETF

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.